Search Results
Search for other papers by Tobias Else in
Google Scholar
PubMed
. This represents a clinical link to other often genetic conditions, such as cyanotic congenital heart disease, and a biological link, as there is a close connection between hypoxia-like signaling changes caused by genetic mutations in VHL - and SDHx
Department of Endocrinology, St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK
Search for other papers by Samuel M O’Toole in
Google Scholar
PubMed
Search for other papers by David S Watson in
Google Scholar
PubMed
Search for other papers by Tatiana V Novoselova in
Google Scholar
PubMed
Search for other papers by Lisa E L Romano in
Google Scholar
PubMed
Search for other papers by Peter J King in
Google Scholar
PubMed
Search for other papers by Teisha Y Bradshaw in
Google Scholar
PubMed
Search for other papers by Clare L Thompson in
Google Scholar
PubMed
Search for other papers by Martin M Knight in
Google Scholar
PubMed
Search for other papers by Tyson V Sharp in
Google Scholar
PubMed
Search for other papers by Michael R Barnes in
Google Scholar
PubMed
Department of Endocrinology, St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK
Department of Diabetes and Endocrinology, University College London Hospital, London, UK
Search for other papers by Umasuthan Srirangalingam in
Google Scholar
PubMed
Search for other papers by William M Drake in
Google Scholar
PubMed
Search for other papers by J Paul Chapple in
Google Scholar
PubMed
comparing individuals with ( n = 5) and without ( n = 22) germline mutations in VHL. (G and H) Cilia incidence and length in 47 PCC/PGL comparing those with a germline mutations in VHL ( n = 9), to tumors from patients with germline mutations in SDHx
Search for other papers by James F Powers in
Google Scholar
PubMed
Search for other papers by Brent Cochran in
Google Scholar
PubMed
Search for other papers by James D Baleja in
Google Scholar
PubMed
Search for other papers by Hadley D Sikes in
Google Scholar
PubMed
Search for other papers by Xue Zhang in
Google Scholar
PubMed
Search for other papers by Inna Lomakin in
Google Scholar
PubMed
Search for other papers by Troy Langford in
Google Scholar
PubMed
Search for other papers by Kassi Taylor Stein in
Google Scholar
PubMed
Search for other papers by Arthur S Tischler in
Google Scholar
PubMed
). In addition, SDHx -mutated paragangliomas are reported to show high levels of markers associated with oxidative stress ( Fliedner et al. 2012 ), which has been proposed as both a driver and inhibitor of tumor progression in other tumor types ( Pani
IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal
Search for other papers by Raquel G Martins in
Google Scholar
PubMed
IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal
Search for other papers by Joana B Nunes in
Google Scholar
PubMed
IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal
Search for other papers by Valdemar Máximo in
Google Scholar
PubMed
IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal
Search for other papers by Paula Soares in
Google Scholar
PubMed
Search for other papers by Joana Peixoto in
Google Scholar
PubMed
Search for other papers by Telmo Catarino in
Google Scholar
PubMed
Search for other papers by Teresa Rito in
Google Scholar
PubMed
Search for other papers by Pedro Soares in
Google Scholar
PubMed
IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal
Search for other papers by Luísa Pereira in
Google Scholar
PubMed
IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal
IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal
Search for other papers by Manuel Sobrinho-Simões in
Google Scholar
PubMed
Search for other papers by Ana Paula Santos in
Google Scholar
PubMed
Search for other papers by Joana Couto in
Google Scholar
PubMed
Search for other papers by Rui Henrique in
Google Scholar
PubMed
Search for other papers by Joana Matos-Loureiro in
Google Scholar
PubMed
Search for other papers by Paula Dias in
Google Scholar
PubMed
Search for other papers by Isabel Torres in
Google Scholar
PubMed
IPATIMUP (Institute of Pathology and Molecular Immunology of the University of Porto), Medical Faculty of the University of Porto, Department of Endocrinology, Department of Pathology, Department of Pathology, Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal
Search for other papers by Jorge Lima in
Google Scholar
PubMed
Dear Editor We would like to report a genetic screening of SDHB , SDHC , SDHD and SDHAF2 genes (hereafter abbreviated to SDHx ) in patients with paragangliomas (PGL) and phaeochromocytomas (PCC) from northern Portugal. PGL and PCC are
Département de Médecine Génomique des Tumeurs et des Cancers, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France
Search for other papers by Anne-Paule Gimenez-Roqueplo in
Google Scholar
PubMed
Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Mays Cancer Center at UTHSCSA, San Antonio, Texas, USA
Search for other papers by Patricia L M Dahia in
Google Scholar
PubMed
( Buffet et al. 2019 ). The study compared the management and outcome of 221 patients diagnosed with PGL carrying mutations in SDHx or VHL who were informed of their positive genetic status either within the first year or more than 7 years after the
Search for other papers by L Fishbein in
Google Scholar
PubMed
Renal and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Search for other papers by S Ben-Maimon in
Google Scholar
PubMed
Division of Medical Oncology and Hematology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Search for other papers by S Keefe in
Google Scholar
PubMed
Search for other papers by K Cengel in
Google Scholar
PubMed
Division of Nuclear Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Search for other papers by D A Pryma in
Google Scholar
PubMed
Division of Medical Oncology and Hematology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Search for other papers by A Loaiza-Bonilla in
Google Scholar
PubMed
Division of Endocrine Oncologic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Search for other papers by D L Fraker in
Google Scholar
PubMed
Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Search for other papers by K L Nathanson in
Google Scholar
PubMed
Renal and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Search for other papers by D L Cohen in
Google Scholar
PubMed
–44.77) and did not differ based on SDHx mutation status ( SDHx carriers 6.80 years vs other 6.39 years; P = 0.8632) or SDHB mutation status ( SDHB carriers 5.99 years vs other 7.38 years; P = 0.5535). The presence of any SDHx mutation was
Search for other papers by Eva Szarek in
Google Scholar
PubMed
Search for other papers by Evan R Ball in
Google Scholar
PubMed
Section on Endocrinology and Genetics (SEGEN), Department of Biophysics and Nuclear Medicine, Faculty of Medicine, Laboratory of Pathology, Section on Medical Neuroendocrinology (SMN), Section of Immunopathology and Laboratory of Immunology, Department of Nuclear Medicine, Institut Paoli‐Calmettes, Emeritus Staff Center, Program on Developmental Endocrinology and Genetics (PDEGEN), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Building 10, CRC, Room 1‐3330, 10 Center Drive, MSC1103, Bethesda, Maryland 20892, USA
Search for other papers by Alessio Imperiale in
Google Scholar
PubMed
Search for other papers by Maria Tsokos in
Google Scholar
PubMed
Search for other papers by Fabio R Faucz in
Google Scholar
PubMed
Search for other papers by Alessio Giubellino in
Google Scholar
PubMed
Section on Endocrinology and Genetics (SEGEN), Department of Biophysics and Nuclear Medicine, Faculty of Medicine, Laboratory of Pathology, Section on Medical Neuroendocrinology (SMN), Section of Immunopathology and Laboratory of Immunology, Department of Nuclear Medicine, Institut Paoli‐Calmettes, Emeritus Staff Center, Program on Developmental Endocrinology and Genetics (PDEGEN), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Building 10, CRC, Room 1‐3330, 10 Center Drive, MSC1103, Bethesda, Maryland 20892, USA
Search for other papers by François-Marie Moussallieh in
Google Scholar
PubMed
Section on Endocrinology and Genetics (SEGEN), Department of Biophysics and Nuclear Medicine, Faculty of Medicine, Laboratory of Pathology, Section on Medical Neuroendocrinology (SMN), Section of Immunopathology and Laboratory of Immunology, Department of Nuclear Medicine, Institut Paoli‐Calmettes, Emeritus Staff Center, Program on Developmental Endocrinology and Genetics (PDEGEN), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Building 10, CRC, Room 1‐3330, 10 Center Drive, MSC1103, Bethesda, Maryland 20892, USA
Search for other papers by Izzie-Jacques Namer in
Google Scholar
PubMed
Search for other papers by Mones S Abu-Asab in
Google Scholar
PubMed
Search for other papers by Karel Pacak in
Google Scholar
PubMed
Section on Endocrinology and Genetics (SEGEN), Department of Biophysics and Nuclear Medicine, Faculty of Medicine, Laboratory of Pathology, Section on Medical Neuroendocrinology (SMN), Section of Immunopathology and Laboratory of Immunology, Department of Nuclear Medicine, Institut Paoli‐Calmettes, Emeritus Staff Center, Program on Developmental Endocrinology and Genetics (PDEGEN), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Building 10, CRC, Room 1‐3330, 10 Center Drive, MSC1103, Bethesda, Maryland 20892, USA
Search for other papers by David Taïeb in
Google Scholar
PubMed
Search for other papers by J Aidan Carney in
Google Scholar
PubMed
Search for other papers by Constantine A Stratakis in
Google Scholar
PubMed
encoded by the SDHA , SDHB, SDHC, and SDHD genes, which are collectively known as SDHx . Mutations in these genes that were known to predispose individuals to hereditary PGLs and pheochromocytomas ( Astuti et al . 2001 , Velasco et al . 2005
Search for other papers by Jenny Welander in
Google Scholar
PubMed
Search for other papers by Peter Söderkvist in
Google Scholar
PubMed
Department of Clinical and Experimental Medicine, Department of Surgery, Faculty of Health Sciences, Linköping University, SE-58185 Linköping, Sweden
Search for other papers by Oliver Gimm in
Google Scholar
PubMed
mutations in any of the genes involved in hereditary pheochromocytoma have been thought to be rare in the more common sporadic form of the tumor, as has repeatedly been reported for the RET , VHL , and SDHx genes ( Burnichon et al . 2011 ). While ∼15
Search for other papers by Frédéric Castinetti in
Google Scholar
PubMed
Search for other papers by Alexander Kroiss in
Google Scholar
PubMed
Search for other papers by Rakesh Kumar in
Google Scholar
PubMed
Search for other papers by Karel Pacak in
Google Scholar
PubMed
Department of Endocrinology, Department of Biophysics and Nuclear Medicine, Diagnostic Nuclear Medicine Division, Program in Reproductive and Adult Endocrinology, Department of Nuclear Medicine, Institut Paoli‐Calmettes, La Timone University Hospital, Aix‐Marseille University, Marseille, France
Search for other papers by David Taieb in
Google Scholar
PubMed
approaches for PHEOs/PGLs according to the localization and genotype Entities Associated conditions 1st choice radiopharmaceuticals 2nd choice radiopharmaceuticals PHEO MEN2 (RET), SDHx, VHL, NF1, TMEM127, MAX 18 F-FDOPA 123 I-MIBG Extraadrenal abdominal and
Search for other papers by Massimo Mannelli in
Google Scholar
PubMed
Search for other papers by Elena Rapizzi in
Google Scholar
PubMed
Search for other papers by Rossella Fucci in
Google Scholar
PubMed
Search for other papers by Letizia Canu in
Google Scholar
PubMed
Search for other papers by Tonino Ercolino in
Google Scholar
PubMed
Search for other papers by Michaela Luconi in
Google Scholar
PubMed
Search for other papers by William F Young Jr in
Google Scholar
PubMed
. 2014 ). Based on gene profiling studies ( Dahia et al . 2005 , Favier et al . 2009 ), mutated as well as WT pheochromocytoma/paraganglioma can be assigned to two different ‘clusters’. Cluster 1 includes VHL , SDHx and FH mutated tumors and is